Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in children

被引:7
作者
Kennedy, MJ
Abdel-Rahman, SM
Kashuba, ADM
Leeder, JS
机构
[1] Univ Louisville, Dept Pediat, Kosair Charities Pediat Clin Res Unit, Louisville, KY 40202 USA
[2] Univ Missouri, Dept Pediat, Pharm Practice, Kansas City, MO 64110 USA
[3] Univ Missouri, Dept Pharmacol, Pharm Practice, Kansas City, MO 64110 USA
[4] Univ N Carolina, Sch Pharm, Div Pharmacotherapy, Chapel Hill, NC USA
[5] Childrens Mercy Hosp & Clin, Div Pediat Clin Pharmacol & Med Toxicol, Kansas City, MO USA
关键词
caffeine; dextromethorphan; phenotyping; urine collection; pediatrics;
D O I
10.1177/0091270004266624
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Caffeine and dextromethorphan have been used Successfully both alone and in combination to assess phenotype and enzyme activity in children of various ages. Previous pediatric phenotyping studies with these agents have used varying durations of Urine collection. However, the minimum duration required for accurate phenotypic assessment with these compounds in children remains unknown. We calculated the cumulative metabolite recoveries and molar ratios in urine collected from children for 2, 4, 6, and 8 hours after caffeine and dextromethorphan administration to determine when respective urinary molar ratios stabilize and thus likely accurately reflect enzyme activity. Subjects (n = 24, ages 3-8 years) were given 4 oz of Coca-Cola(R) (similar to11.5 mg caffeine) and a single oral dose of dextromethorphan (0.5 mg/kg). Urine was collected at discrete intervals (0-2, 2-4, 4-6, and 6-8 h) during an 8-hour period, and the cumulative metabolite recoveries and urinary molar ratios were calculated. CYP2D6 genotyping was also performed in 21 of 24 subjects. In CYP2D6 extensive metabolizers, the extent of recovery for relevant metabolites was equivalent by 4 hours and represented 45% to 60% of the total amount recovered in the 8-hour period. The 2-hour CYP1A2 ratio was significantly different from those of longer collection intervals. Metabolite ratios for all other enzymes (i.e., NAT-2, XO, and CYP2D6) were independent of the duration of urine collection. These data suggest that a 4-hour urine collection is adequate for the concurrent assessment of hepatic CYP1A2, NAT-2, XO, and CYP2D6 activity in children ages 3 to 8 years who are CYP2D6 extensive metabolizers, using standard caffeine and dextromethorphan phenotyping methods. Longer collection periods may be required, however, in younger children or CYP2D6 poor metabolizers.
引用
收藏
页码:708 / 714
页数:7
相关论文
共 28 条
[1]  
Abdel-Rahman SM, 1999, DRUG METAB DISPOS, V27, P770
[2]   Concordance between tramadol and dextromethorphan parent/metabolite ratios: The influence of CYP2D6 and non-CYP2D6 pathways on biotransformation [J].
Abdel-Rahman, SM ;
Leeder, JS ;
Wilson, JT ;
Gaedigk, A ;
Gotschall, RR ;
Medve, R ;
Liao, S ;
Spielberg, SP ;
Kearns, GL .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (01) :24-29
[3]   Investigation of terbinafine as a CYP2D6 inhibitor in vivo [J].
Abdel-Rahman, SM ;
Gotschall, RR ;
Kauffman, RE ;
Leeder, JS ;
Kearns, GL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (05) :465-472
[4]  
Bosso JA, 1996, PHARMACOTHERAPY, V16, P749
[5]   A URINARY METABOLITE RATIO THAT REFLECTS SYSTEMIC CAFFEINE CLEARANCE [J].
CAMPBELL, ME ;
SPIELBERG, SP ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) :157-165
[6]   DEXTROMETHORPHAN AND CAFFEINE AS PROBES FOR SIMULTANEOUS DETERMINATION OF DEBRISOQUIN-OXIDATION AND N-ACETYLATION PHENOTYPES IN CHILDREN [J].
EVANS, WE ;
RELLING, MV ;
PETROS, WP ;
MEYER, WH ;
MIRRO, J ;
CROM, WR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (05) :568-573
[7]   Evaluation of caffeine as a test drug for CYPIA2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations [J].
Fuhr, U ;
Rost, KL ;
Engelhardt, R ;
Sachs, M ;
Liermann, D ;
Belloc, C ;
Beaune, P ;
Janezic, S ;
Grant, D ;
Meyer, UA ;
Staib, AH .
PHARMACOGENETICS, 1996, 6 (02) :159-176
[8]   Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans [J].
Gaedigk, A ;
Bradford, LD ;
Marcucci, KA ;
Leeder, JS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (01) :76-89
[9]   Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data [J].
Gaedigk, A ;
Gotschall, RR ;
Forbes, NS ;
Simon, SD ;
Kearns, GL ;
Leeder, JS .
PHARMACOGENETICS, 1999, 9 (06) :669-682
[10]   A SIMPLE TEST FOR ACETYLATOR PHENOTYPE USING CAFFEINE [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) :459-464